Clinical Research Trials Available

Search Results

ML25749

Disease Types: Breast

USOR 14-184
A Phase 1b/2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with B-cell Malignancies

Disease Types: Diffuse Large B-cell Lymphoma

USOR 13-177
A Phase II, Open-Label Study of Obinutuzumab Plus Bendamustine (BG) in Patients with Previously Untreated Chronic Lymphocytic Leukemia

Disease Types: Chronic Lymphocytic Leukemia

USOR 14-052
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Subjects with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

Disease Types: Breast

USOR 14-114 “TIGER 1”
A Randomized, Open-Label, Phase II Study of CO-1686 or Erlotinib as First-Line Treatment of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)

Disease Types: Non-Small Cell Lung Cancer

USO 13-057
A Phase II Clinical Study of BBI608 in Adult Patients with Advanced Colorectal Cancer

Disease Types: Colorectal

USOR 13-079
A Phase III randomized, 3-arm, open label, multicenter study of LGX818 plus MEK162 and LGX818 monotherapy compared with vemurafenib in patients with unresectable or metastatic BRAF V600 mutant melanoma

Disease Types: Melanoma

Galena/Genentech ML25749
Combination immunotherapy with Herceptin and the HER2 vaccine E75 in low and intermediate HER2-expressing breast cancer patients to prevent recurrence

Disease Types: Breast

USOR 13-056
A phase 2 study of brentuximab vedotin in combination with standard of care treatment (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [RCHOP]) as front-line therapy in patients with diffuse large B-cell lymphoma (DLBCL)

Disease Types: Diffuse Large B-cell Lymphoma

USO 12-154
A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Subjects with Relapsed or Refractory Hematologic Malignancies (GS-US-339-0102)

Disease Types: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma, Small Lymphocytic Leukemia